Intel Corporation

(NASDAQ Global Select)
Back to all articles
Slightly Bearish -15

The Government’s $37 Billion Intel Round Trip Is a Warning for Anyone Who Still Holds the Stock

Earnings report Financial outlook AI-generated analysis

📉 Intel shares fell from a June record close of $140.94 to Friday's close of $56.28, representing a roughly 60% decline and a $37 billion loss in value for the government stake.

💰 A retired engineer holding 4,000 shares saw their position drop from $563,760 to $225,120 in five months, reducing Intel's share of their portfolio from 32% to 15.8%.

📊 Intel reported record third-quarter revenue of $16.5 billion with data center revenue up 78%, but issued a fourth-quarter guidance of $15.0B-$16.0B revenue and 25 cents EPS.

💻 PC chip revenue is expected to decline more than 20% from the third quarter, with weakness projected to persist through at least the first half of 2027.

🎯 The average analyst target price for Intel is $91.12, which is 62% higher than Friday's closing price of $56.28.

📈 Intel trades at approximately 33 times expected earnings despite the recent stock price correction and mixed guidance outlook.

🔄 Selling half of a concentrated position in December and January can save investors roughly $6,122 in federal taxes compared to selling everything at once.

⚠️ Swapping Intel for other semiconductor stocks like Arm or Marvell exposes investors to similar risks without necessarily improving diversification.

📉 The stock has lost about $890 billion in market value alongside Nvidia and Arm since their respective June record highs.

💡 Diversifying into a low-cost S&P 500 index fund could yield an estimated 5.8% annual return over ten years, potentially matching analyst price targets.

Bullish Signals
  • Intel reported third-quarter revenue of $16.5 billion, a 21% increase year-over-year, driven by data center revenue that grew 78% to $7.3 billion.
  • Management stated that demand for its server chips still exceeds current supply capacity, indicating strong underlying market interest in the data center segment.
  • The average analyst target price is $91.12, implying a potential upside of 62% from Friday's closing price of $56.28.
Risk Factors
  • The stock has fallen approximately 60% from its June record high, causing significant unrealized losses for investors holding concentrated positions.
Full Analysis
The article analyzes the dramatic decline of Intel (INTC) stock, noting that a government stake bought at $20.47 in August 2025 lost approximately $37 billion in value as shares fell from a June record of $140.94 to Friday's close of $56.28. This sharp drop serves as a warning for individual investors, particularly retirees holding concentrated positions, who face significant unrealized losses and concentration risk without the government's ability to absorb such volatility. Despite the stock price collapse, Intel reported strong third-quarter fundamentals with revenue rising 21% to $16.5 billion and data center revenue surging 78% to $7.3 billion, marking the fastest growth in 15 years. However, management issued a cautious fourth-quarter outlook forecasting revenue between $15.0 billion and $16.0 billion and adjusted earnings of 25 cents per share, which is less than half of the previous quarter's reported results. The article highlights that PC chip revenue is expected to drop more than 20% from the third quarter, with weakness anticipated to last into the first half of 2027. Consequently, Intel trades at about 33 times expected earnings despite an average analyst target price of $91.12, suggesting a potential upside of 62%. The piece advises investors on tax-efficient strategies to reduce concentration risk by selling portions of their holdings in December and January. Financial experts suggest that swapping Intel for other semiconductor stocks like Arm or Marvell merely changes the name of the risk without altering the underlying exposure. The recommendation is to diversify into broad market index funds, which could yield 5.8% annually over ten years, potentially matching or exceeding analyst price targets while avoiding reliance on a single company's recovery.